Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Poetschger, Ulrike  [Clear All Filters]
2023
Flaadt T, Ladenstein RL, Ebinger M, Lode HN, Arnardóttir HBjörk, Poetschger U, Schwinger W, Meisel R, Schuster FR, Döring M, et al. Anti-GD2 Antibody Dinutuximab Beta and Low-Dose Interleukin 2 After Haploidentical Stem-Cell Transplantation in Patients With Relapsed Neuroblastoma: A Multicenter, Phase I/II Trial. J Clin Oncol. 2023:JCO2201630.
Bader P, Poetschger U, Dalle J-H, Moser LM, Balduzzi ACristina, Ansari M, Buechner J, Güngör T, Ifversen M, Kriván G, et al. Low rate of nonrelapse mortality in under 4-year-olds with ALL given chemo-conditioning for HSCT: Phase III FORUM study. Blood Adv. 2023.
2019
Pichler H, Lawitschka A, Glogova E, Willasch AM, von Luettichau I, Lehrnbecher T, Matthes-Martin S, Lang P, Bader P, Sykora KW, et al. Allogeneic hematopoietic stem cell transplantation from unrelated donors is associated with higher infection rates in children with acute lymphoblastic leukemia - A prospective international multicenter trial on behalf of the BFM-SG and the EBMT-PDWP. Am J Hematol. 2019.
Balduzzi A, Dalle J-H, Wachowiak J, Yaniv I, Yeşilipek A, Sedlacek P, Bierings M, Ifversen M, Sufliarska S, Kalwak K, et al. TRANSPLANTATION IN CHILDREN AND ADOLESCENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA FROM A MATCHED DONOR VERSUS AN HLA-IDENTICAL SIBLING: IS THE OUTCOME COMPARABLE? RESULTS FROM THE INTERNATIONAL BFM ALL SCT 2007 STUDY. Biol Blood Marrow Transplant. 2019.